Madiog, Merita M.
HRN: 27-22-53 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2025
CO-AMOXICLAV 625MG (TAB)
06/01/2025
06/08/2025
PO
625MG
BID
AVULSED WOUND
Waiting Final Action